Universe Pharmaceuticals (UPC) Notes Payables (2020 - 2025)
Historic Notes Payables for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $7149.9 billion.
- Universe Pharmaceuticals' Notes Payables rose 2208.03% to $7149.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7149.9 billion, marking a year-over-year increase of 2208.03%. This contributed to the annual value of $7149.9 billion for FY2025, which is 2208.03% up from last year.
- Universe Pharmaceuticals' Notes Payables amounted to $7149.9 billion in Q3 2025, which was up 2208.03% from $5856.7 billion recorded in Q3 2024.
- Universe Pharmaceuticals' Notes Payables' 5-year high stood at $7149.9 billion during Q3 2025, with a 5-year trough of $3.9 million in Q3 2022.
- In the last 5 years, Universe Pharmaceuticals' Notes Payables had a median value of $4.4 million in 2022 and averaged $1625.8 billion.
- As far as peak fluctuations go, Universe Pharmaceuticals' Notes Payables plummeted by 9999.98% in 2021, and later surged by 10682616545.48% in 2024.
- Over the past 5 years, Universe Pharmaceuticals' Notes Payables (Quarter) stood at $4.3 million in 2021, then decreased by 9.19% to $3.9 million in 2022, then skyrocketed by 39.28% to $5.5 million in 2023, then skyrocketed by 106826165.45% to $5856.7 billion in 2024, then grew by 22.08% to $7149.9 billion in 2025.
- Its Notes Payables was $7149.9 billion in Q3 2025, compared to $5856.7 billion in Q3 2024 and $4.4 million in Q1 2024.